NCT03965468
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03965468
Title Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC (CHESS)
Acronym CHESS
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors ETOP IBCSG Partners Foundation
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | ITA | ESP | CHE

Facility Status City State Zip Country Details
European Institute of Oncology Milan Italy Details
Istituto Oncologico Veneto - Irccs Padua Italy Details
IRCCS Istituto Nazionale Tumori Regina Elena Roma Italy Details
Maastricht University Medical Center Maastricht Netherlands Details
Erasmus Medical Centre Rotterdam Netherlands Details
Hosp. De la Santa Creu i Sant Pau Barcelona Spain Details
Hosp. Uni. Virgen de las Nieves Granada Spain Details
Hosp. Sanchinarro- Centro Integral Oncología Clara Campal Madrid Spain Details
Vall d'Hebron University Hospital Madrid Spain Details
Hosp. Uni. Politécnico La Fe Valencia Spain Details
Inselspital Bern Bern Switzerland Details
Geneva University Hospital Geneva Switzerland Details
Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne Switzerland Details
Kantonsspital Winterthur Winterthur Switzerland Details
University Hospital Zurich Zurich Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field